MENU
From Medical News Today Pierrel Research USA, Inc., a subsidiary of Pierrel SpA, the Italian-based, global pharmaceutical services company, announces the US launch of Orabloc™ (Articaine hydrochloride 4% with epinephrine 1:100,000 and Articaine hydrochloride 4% with epinephrine 1:200,000). Orabloc is…
We use cookies to make your website experience better. By accepting this notice and continuing to browse our website you confirm you accept our Terms of Use & Privacy Policy.
read more >>
View Print Edition
View Digital Edition
View Special Edition